PRKAG2 and myocardial ischemia: In the hearts of patients with ischemic cardiomyopathy, PRKAG2-AS, PRKAG2b, and PRKAG2d were all reduced, pointing to a potential involvement of PRKAG2-AS in reducing myocardial ischemia.